I K Anderson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

I K Anderson

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

British Journal of Pharmacology|August 24, 2012

Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritisR R Minter, E S Cohen, B Wang, et al.

British Journal of Pharmacology|September 8, 2011

Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthmaR D May, P D Monk, E S Cohen, et al.

Annals of the Rheumatic Diseases|June 18, 2014

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritisD E A Greven, E S Cohen, D M Gerlag, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

British Journal of Pharmacology|August 24, 2012

Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritisR R Minter, E S Cohen, B Wang, et al.

British Journal of Pharmacology|September 8, 2011

Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthmaR D May, P D Monk, E S Cohen, et al.

Annals of the Rheumatic Diseases|June 18, 2014

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritisD E A Greven, E S Cohen, D M Gerlag, et al.

Pageof 2